Ophtesic (Anhydrous Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on sensory nerve fibers in the eye. By preventing sodium influx, it stops the generation and propagation of nerve impulses, producing a rapid and reversible loss of sensation in the treated ocular tissues.

The prescribed dose of Ophtesic is determined by the treating clinician based on the specific procedure and patient factors. Typically, a few drops are instilled onto the ocular surface shortly before the intended intervention, following the prescriber’s instructions.

Safety data for lidocaine ophthalmic use in pregnancy and lactation are limited. It should be used only if the potential therapeutic benefit justifies any potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To order Ophtesic, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ophtesic contains lidocaine, an amide‑type anesthetic with a rapid onset and moderate duration. Compared with ester‑type agents such as proparacaine or tetracaine, lidocaine often provides a slightly longer anesthetic window and a well‑characterised safety profile, making it a common choice for many ophthalmic procedures.

Ophtesic should be stored at ambient temperature, protected from light and moisture, and kept in its original container. Do not freeze the product. Once opened, use within the period recommended by the manufacturer and discard any solution that appears cloudy or contaminated.

Ophtesic is applied topically to the eye as a sterile drop. The prescriber directs the number of drops and the timing relative to the procedure. The patient should keep the eyelids closed for a short period after instillation to allow adequate absorption.

Serious risks, although rare, include severe allergic reactions such as anaphylaxis, corneal epithelial defects or ulceration with prolonged use, and systemic toxicity (e.g., central nervous system symptoms) if excessive amounts are absorbed. Immediate medical attention is required if any of these occur.

Ophtesic should not be used in individuals with a known hypersensitivity to lidocaine or other amide‑type local anesthetics. Caution is also advised for patients with severe cardiac conduction disorders, uncontrolled epilepsy, or those taking medications that may increase lidocaine levels.